We think the strategy to find more effective combination therapies in hematology and build a larger oncology and dermatology portfolio is solid, although we're waiting for key data before assuming the ...

For Q1 2025, BlackLine projects revenue between $166M and $168M and non-GAAP operating margin of 16.5%-17.5%. Full-year 2025 revenue guidance stands at $699M to $705M, reflecting 7%-8% growth.